For the Culture By The Culture. ISSN: 3064-9331.
The DEA’s delay in rescheduling cannabis is just a temporary hurdle for an industry and movement that refuses to be slowed down. Cannabis was once part of the counter-culture, now it is the culture. The future of cannabis is bright, and nothing is going to stop it
How Every Generation Got High. Explore how the Baby Boomers transformed cannabis from a counterculture symbol to a mainstream movement, from the highs of Woodstock to the lows of the War on Drugs
Matthew Perry's death wasn't just a tragic accident; it’s a stark reminder of the deadly mix of addiction and personal choices. The investigation digs deep into the grim reality of his demise
In a historic move, the U.S. Justice Department proposes reclassifying marijuana from a Schedule One to a Schedule Three drug. This shift could open doors to more research and investment in the cannabis sector, aligning federal laws closer to state realities.
Explore how the Biden administration's proposal to reclassify marijuana could unlock new research opportunities and transform the regulatory landscape in Mississippi. Image: Suggested image of a research lab with cannabis plants in focus, capturing the essence of new beginnings in cannabis research
As rumors swirl about a potential DEA announcement to reschedule cannabis, the implications for medical research and industry regulations could be transformative. Will the DEA's decision ignite a new era for cannabis in America? Stay tuned for a groundbreaking shift in drug policy dynamics.
